Global Sustainable Pharmaceutical Packaging Market Size Likely to Surpass at a CAGR of 15.13% By 2034

Sustainable Pharmaceutical Packaging Market Size

As per the Sustainable Pharmaceutical Packaging Market size analysis conducted by the CMI Team, the global Sustainable Pharmaceutical Packaging Market is expected to record a CAGR of 15.13% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 96.54 Billion. By 2034, the valuation is anticipated to reach USD 343.01 Billion.

Sustainable Pharmaceutical Packaging Market Overview

Green Packaging Industry for the Pharmaceutical Industry is expanding very rapidly because companies are paying more and more attention to green processes due to mounting regulatory pressures, environmental awareness, and consumer demand for increasingly sustainable options.

Companies are using biodegradable and renewable packaging materials, making investments in cutting-edge, state-of-the-art technology for minimizing waste and carbon consumption, and designing minimalist and reuse-focused packaging platforms. This exponential growth is also enhanced by cross collaboration across the supply chain, innovation by renewable materials, and embracing circular economy philosophy to make pharma packaging function, be safe, and sustainable

Sustainable Pharmaceutical Packaging Market Growth Factors and Dynamics

• Increasing Green Consciousness: The global rising concern for environmental issues, such as plastic contamination and carbon impact, has established heightened consciousness among consumers, governments, and companies. The consciousness drives demand for eco-friendly packaging solutions that contribute minimal ecological traces while maintaining product integrity. For example, in March 2025, Berry Global’s 2024 Sustainability Report highlights significant progress in circularity and climate objectives, such as a 43% increase in post-consumer resin use, 130% growth in bioplastics, 93% recyclability of packaging, and product design for sustainability. Scope 1 and 2 emissions reduced by 28.3% since 2019, renewable energy consumption increased by 31%, and workplace safety and engagement were improved. They were rewarded with an MSCI AA rating and EcoVadis Gold, proving their dedication to a net-zero, inclusive future.

• Advances in Technology: Advances in technology in the manufacturing process and material science have enabled mass production of eco-friendly packaging materials meeting the extremely stringent specifications of the pharmaceutical sector. Such innovations involve the production of recyclable, degradable, and compostable packaging items that ensure product efficacy and safety. For example, Amcor’s November 2024 sustainability targets, as reported by the Ellen MacArthur Foundation’s Global Commitment Report, are achieving the recyclability of 94% of its flexible packaging and 95% of its rigid packaging, 9.4% PCR in plastics, and growing its AmFiniti recycled material portfolio. The company also achieved a 9% year-on-year reduction in greenhouse gas emissions, contributing to a total 3.4 million-ton CO₂ reduction by signatories. In celebrating industry achievement, Amcor and the Foundation urge further global action and regulation to end plastic waste.

• Green Product Consumer Demand: Contemporary consumers are increasingly concerned about their consumption habits. Such a change in consumer behavior compels pharma companies to shift toward green packaging solutions in an attempt to match market demand as well as customer loyalty. For example, in February 2025, Berry Global launched CleanStream Home and Industrial, a high-purity post-consumer recycled (PCR) plastic for non-contact-sensitive packaging in the homecare and industrial segments. Developed with state-of-the-art AI-based decontamination and sorting, it is perfect for high-performance uses such as trigger sprays and paint cans. The plant, headquartered in Leamington Spa, UK, enables closed-loop recycling, which reduces the carbon footprint by 35% compared to virgin plastic and saves 36,000 tonnes of CO₂ annually. The technology is designed to match the rising demand for high-performance, sustainable packaging without a reduction in quality.

Report Scope

Sustainable Pharmaceutical Packaging SWOT Analysis

• Strengths: Green pharmaceutical packaging involves massive environmental advantages via plastic waste reduction, renewable feedstock utilization, and promotion of global climate goals. Solutions yield improved brand equity, regulatory acceptance, and consumer confidence. Companies adopting green packaging are then considered innovators and socially responsible. Green packaging also involves improved product protection via the utilization of non-hazardous, inert materials. Moreover, investment in recyclable and biodegradable forms promotes long-term cost savings via circular economy models.

• Weaknesses: Massive upfront investment in eco-friendly materials and technologies confronts the sector. Limited availability of high-tech green materials may delay massive adoption. Biodegradable and recyclable substitutes will not necessarily replicate the same barrier properties as traditional materials, affecting product shelf life. Recycling or composting facilities are still underdeveloped in most regions. Minimal knowledge and unwillingness to adopt innovation among smaller pharma manufacturers exist too.

• Opportunities: Increased global demand for green solutions provides an enormous market opportunity for sustainable pharmaceutical packaging. EU, U.S., and Asian regulatory agencies are increasingly supporting environmentally friendly packaging, leading to adoption. Innovation opportunities through advancements in bio-based polymers and smart packaging provide new paths. Collaborations with biotech and packaging companies can speed up R&D. Additionally, heightened consumer health awareness is driving the demand for cleaner, greener packaging options.

• Threats: Unpredictable raw material prices and supply chain disruptions—particularly for recycled or bio-based feedstocks—threaten stable production. Regulatory changes sometimes add cost or complexity of compliance regionally. Allegations of greenwashing and the risks of non-harmonized definitions erode consumer trust. To some degree, economically inefficient suppliers of traditional packaging can preclude sustainable alternatives through cost competition. Finally, poor economic performance in certain markets can restrict investment in sustainable infrastructure.

List of the prominent players in the Sustainable Pharmaceutical Packaging Market:

• Amcor plc
• Berry Global Inc.
• Sonoco Products Company
• WestRock Company
• CCL Healthcare
• SGD Pharma
• OLIVER
• Gerresheimer AG
• West Pharmaceutical Services Inc.
• Nottingham Spirk
• Crown Packaging Corp.
• Nipro Europe Group Companies
• Origin Pharma Packaging
• Syntegon Technology GmbH
• Bormioli Pharma S.p.A.
• Others

The Sustainable Pharmaceutical Packaging Market is segmented as follows:

By Material

• Plastics
• Paper & paperboard
• Glass
• Metal
• Others

By Product Type

• Plastic bottles
• Blister
• Pre-filled inhalers
• Ampoules
• Jars & Canisters

By Process

• Recyclable
• Reusable
• Biodegradable

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America